EU SaMD rule tightens AI validation from Oct 2026, requiring real-world clinical performance evidence. Learn what AI medical software exporters, CE teams, and buyers must do now.

SaMD pricing compared: explore license, subscription, and outcome-based fees, uncover hidden costs, and choose the right model for scalable, compliant digital health growth.

FDA opens a faster remote review path for SaMD exports, cutting review cycles to 45 working days. See how AI imaging, digital pathology, and remote monitoring firms can gain faster U.S. market access.